Who owns APELLIS PHARMACEUTICALS INC?
- CUSIP Number: 03753uab2
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apellis Pharmaceuticals stock
Who bought or sold APELLIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DeepCurrents Investment Group | 26M | $43M | -35% | Mar 2024 |
|
| Lazard Asset Management | 16M | $26M | 30% | Dec 2023 |
|
| Verition Fund Management | 13M | $21M | 102429% | Mar 2024 |
|
| Tenor Capital Management | 11M | $18B | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 5.0M | $8.2M | 0% | Mar 2024 |
|
| Opti Capital Management | 3.8M | $6.2M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.6M | $2.5M | -38% | Mar 2024 |
|
| CSS | 1.5M | $2.5M | 100% | Mar 2024 |
|
| Wellington Management Company | 1.3M | $2.1M | 0% | Dec 2023 |
|
| Lord, Abbett & Co | 1.1M | $1.9M | 100% | Mar 2024 |
|
| Kornitzer Capital Management | 300k | $487k | 0% | Mar 2024 |
|
| Citigroup | 6.0k | $9.8k | -99% | Mar 2024 |
|
Who sold out of Apellis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 15M | $19B |
| Wolverine Asset Management | Dec 2023 | 12M | $19M |
| Palisade Capital Management | Dec 2023 | 1.0M | $1.7M |